BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15213342)

  • 1. Visceral leishmaniasis in a patient with Wegener's granulomatosis.
    Sollima S; Corbellino M; Piolini R; Calattini S; Imparato S; Antinori S
    Rheumatology (Oxford); 2004 Jul; 43(7):935-7. PubMed ID: 15213342
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral leishmaniasis caused by Leishmania infantum in Thailand.
    Maharom P; Siripattanapipong S; Mungthin M; Naaglor T; Sukkawee R; Pudkorn R; Wattana W; Wanachiwanawin D; Areechokchai D; Leelayoova S
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):988-90. PubMed ID: 19062685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
    Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
    Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
    [No Abstract]   [Full Text] [Related]  

  • 4. An unwelcome synergy: leishmaniasis and HIV.
    Colasanti J; Altamirano J; Espinoza L
    Am J Med; 2013 Feb; 126(2):114-6. PubMed ID: 23331437
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.
    Beltrame A; Arzese A; Camporese A; Rorato G; Crapis M; Tarabini-Castellani G; Boscutti G; Pizzolitto S; Calianno G; Matteelli A; Di Muccio T; Gramiccia M; Viale P
    J Travel Med; 2008; 15(5):358-60. PubMed ID: 19006511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lingual leishmaniasis complicating visceral disease.
    Mazumder SA; Pandey S; Brewer SC; Baselski VS; Weina PJ; Land MA; Fleckenstein JM
    J Travel Med; 2010; 17(3):212-4. PubMed ID: 20536896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-kala-azar dermal leishmaniasis caused by Leishmania infantum in an immunocompetent patient.
    Sánchez-Albisua B; Polimón I; Pérez-Tato B; Marinero S; Fernández-López P
    Int J Dermatol; 2013 Jul; 52(7):897-9. PubMed ID: 23675968
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
    Vase MØ; Hellberg YK; Larsen CS; Petersen E; Schaumburg H; Bendix K; Ravel C; Bastien P; Christensen M; d'Amore F
    Acta Haematol; 2012; 128(1):20-2. PubMed ID: 22572474
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of visceral leishmaniasis.
    Ozsoylu S
    Turk J Pediatr; 2003; 45(3):280. PubMed ID: 14696814
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis.
    Tapisiz A; Belet N; Ciftçi E; Ince E; Dogru U
    J Trop Pediatr; 2007 Oct; 53(5):359-61. PubMed ID: 17626064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of visceral leishmaniasis with liposomal amphotericin B.
    Lagler H; Matt U; Sillaber C; Winkler S; Graninger W
    Acta Biomed; 2006; 77 Suppl 2():22-5. PubMed ID: 16918063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Visceral leishmaniasis in immunocompetent adult with severe sepsis].
    Ezzouine H; Charra B; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2010 Mar; 29(3):255-6. PubMed ID: 20227234
    [No Abstract]   [Full Text] [Related]  

  • 14. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
    Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fever, pancytopenia, and splenomegaly 8 months after a trip to Majorca Island (Spain)].
    Lübbert C; Opitz BM; Harms-Zwingenberger G; Nietsch HH
    Med Klin (Munich); 2008 Jan; 103(1):29-35. PubMed ID: 18219460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral leishmaniasis and Coombs' positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B.
    Dilber E; Erduran E; Işik Y
    Turk J Pediatr; 2002; 44(4):354-6. PubMed ID: 12458816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin rash for 15 years.
    Montelius S; Maasho K; Pratlong F; Lebbad M; Gregory L; Akuffo H
    Lancet; 1998 Oct; 352(9138):1438. PubMed ID: 9807991
    [No Abstract]   [Full Text] [Related]  

  • 20. Leishmaniasis due to L. infantum presenting as macrocheilitis and responding to liposomal amphotericin B.
    Rongioletti F; Cannata GE; Parodi A
    Eur J Dermatol; 2009; 19(3):281-2. PubMed ID: 19286487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.